Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 28 February 2015 and unaudited. Performance at month end with net income reinvested One Three One Three Launch Month Months Year Years (20 Sep 04) Net asset value* (undiluted) 2.6% 3.5% 1.2% 45.6% 208.0% Net asset value* (diluted) 2.2% 3.1% 2.5% 45.4% 207.1% Share price 0.8% 2.5% -1.7% 38.7% 190.9% FTSE World Europe ex UK 3.0% 2.3% 5.2% 43.9% 149.6% Sources: BlackRock and Datastream At month end Net asset value (capital only): 253.17p Net asset value (including income): 253.88p Net asset value (capital only)*: 252.33p Net asset value (including income)*: 252.92p Share price: 238.25p Discount to NAV (including income): 6.2% Discount to NAV (including income)*: 5.8% Subscription share price: 12.00p Net gearing: 0.5% Net yield**: 2.0% Total assets (including income): £277.70m Ordinary shares in issue***: 105,676,343 Subscription shares: 20,633,300 Ongoing charges****: 0.94% * Diluted for subscription shares and treasury shares. ** Based on a final dividend of 3.2p and an interim dividend of 1.5p per share for the year ended 31 August 2014. *** Excluding 5,561,653 shares held in treasury. **** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs, after relief for taxation for the year ended 31 August 2014. Sector Analysis Total Assets (%) Country Analysis Total Assets (%) Financials 32.8 Germany 17.0 Consumer Goods 18.2 France 16.4 Industrials 15.1 Switzerland 13.5 Health Care 8.0 Italy 11.5 Consumer Services 6.9 Netherlands 7.3 Technology 6.1 Sweden 6.9 Base Materials 4.8 Ireland 6.4 Telecommunications 2.8 Denmark 5.4 Utilities 2.4 Belgium 3.3 Net current assets 2.9 Turkey 3.2 ----- Finland 2.6 100.0 Russia 2.5 ===== Spain 1.1 Net current assets 2.9 ----- 100.0 ===== Ten Largest Equity Investments % of Company Country Total Assets Novo-Nordisk Denmark 4.6 Novartis Switzerland 4.2 Roche Switzerland 3.8 Bayer Germany 3.6 KBC Groep Belgium 3.3 AXA France 3.2 Daimler Germany 3.2 Intesa Sanpaolo Italy 3.1 Deutsche Telekom Germany 2.8 Heineken Netherlands 2.7 Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: During the month, the Company's NAV returned +2.6% and the share price returned +0.8%. For reference, the FTSE World Europe ex UK Index returned +3.0% during the same period. (All in Sterling terms with income reinvested). European Equity markets rallied strongly in February, outperforming most other equity markets globally. Sentiment was buoyed by the European Central Bank's (ECB) announcement of Quantitative Easing (QE) towards the end of January and an eventual extension to the Greek bailout package by four months. Economic indicators for Europe also continued to pick up, with consumer confidence increasing, positive manufacturing data and German New Orders for December significantly exceeding expectations. Within the market, cyclical sectors tended to outperform, continuing a trend established towards the end of 2014. Financials, Basic Materials and Industrials led the market, along with Oil & Gas which rallied as the oil price found a floor. Small and mid-cap stocks also outperformed larger stocks. As a result of this improved sentiment, investors began to buy back into Europe as a source of both relative value and positive economic momentum when compared with other regions such as the US. Stock selection was the primary driver of fund underperformance during February. Sector allocation, however, was a positive contributor. The larger exposure to Financials and limited exposure to Utilities were positive for performance. Detractions on a sector basis came from the Company's larger exposure to Health Care and lesser exposure to Utilities. Stock selection within the financials industry was the largest detractor to performance during the month. This was largely driven by holdings in Turkish banks T Granti and Turkiye Halk Banka. The Turkish banking sector was weak across the board during February. This was driven mainly by increased political pressure from President Erdogan on the central bank to speed up interest rate cuts. This sparked fears that the measures taken in 2014 to support the Lira would be reversed sooner than expected. A number of large cap names also detracted, including Zurich Insurance and Unilever, as this area of the market began to decline. Zurich Insurance also saw downgrades after reporting weaker than expected full year results. Sberbank of Russia, KBC Groep, Intesa Sanpaolo and Bank of Ireland were contributors during February as the banking sector in Europe generally rallied due to supportive policy measures coming from the ECB. Bank of Ireland, particularly, has rallied as Irish economic confidence and sentiment has improved. At the end of the month, the Company had higher exposure to Financials, Technology and Consumer Services. The Company had less exposure to Oil & Gas, Basic Materials, Health Care, Utilities, Consumer Goods and Telecoms. The Company's exposure to Industrials was in line with the benchmark. Outlook The European market has grown 15% year-to-date, driven by the supportive ECB action in January. The key aspect we should focus on is the fact that the European economy is now recovering driven by supportive action in terms of QE, the weak Euro and lower oil price. QE is going to inject €60bn a month into Europe and this will not only apply downward pressure on bond yields, but will also have repercussions for European companies. The cost of debt for companies has collapsed over the last six months and we believe that companies are going to take advantage of the favourable financing conditions to issue more and cheaper debt both to refinance existing debt and/or to acquire other businesses. Moreover, the economic recovery is going to drive demand and earnings higher, which should be supportive for markets. As the recovery continues to gather momentum, and as the ECB rolls out its QE programme, we believe that the elevated risk premium on European equities has room to fall further from here. 16 March 2015 ENDS Latest information is available by typing www.brgeplc.co.ukon the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings